Is atai Life Sciences (ATAI) Stock Outpacing Its Medical Peers This Year?
Werte in diesem Artikel
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. atai Life Sciences N.V. (ATAI) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.atai Life Sciences N.V. is one of 999 individual stocks in the Medical sector. Collectively, these companies sit at #5 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. atai Life Sciences N.V. is currently sporting a Zacks Rank of #2 (Buy).Over the past three months, the Zacks Consensus Estimate for ATAI's full-year earnings has moved 0.8% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.Based on the most recent data, ATAI has returned 81.2% so far this year. At the same time, Medical stocks have lost an average of 3.4%. This means that atai Life Sciences N.V. is performing better than its sector in terms of year-to-date returns.One other Medical stock that has outperformed the sector so far this year is Novartis (NVS). The stock is up 21.3% year-to-date.The consensus estimate for Novartis' current year EPS has increased 3.2% over the past three months. The stock currently has a Zacks Rank #2 (Buy).Looking more specifically, atai Life Sciences N.V. belongs to the Medical - Outpatient and Home Healthcare industry, which includes 17 individual stocks and currently sits at #64 in the Zacks Industry Rank. Stocks in this group have gained about 5.1% so far this year, so ATAI is performing better this group in terms of year-to-date returns.On the other hand, Novartis belongs to the Large Cap Pharmaceuticals industry. This 11-stock industry is currently ranked #42. The industry has moved -1.1% year to date.Investors with an interest in Medical stocks should continue to track atai Life Sciences N.V. and Novartis. These stocks will be looking to continue their solid performance.Zacks Names #1 Semiconductor StockIt's only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more room to boom.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $803 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report atai Life Sciences N.V. (ATAI): Free Stock Analysis Report Novartis AG (NVS): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf atai Life Sciences
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf atai Life Sciences
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu atai Life Sciences
Keine Nachrichten im Zeitraum eines Jahres in dieser Kategorie verfügbar.
Eventuell finden Sie Nachrichten, die älter als ein Jahr sind, im Archiv
Analysen zu atai Life Sciences
Keine Analysen gefunden.